NO20016099L - Optisk aktive pyrrolopyridazinforbindelser - Google Patents

Optisk aktive pyrrolopyridazinforbindelser

Info

Publication number
NO20016099L
NO20016099L NO20016099A NO20016099A NO20016099L NO 20016099 L NO20016099 L NO 20016099L NO 20016099 A NO20016099 A NO 20016099A NO 20016099 A NO20016099 A NO 20016099A NO 20016099 L NO20016099 L NO 20016099L
Authority
NO
Norway
Prior art keywords
optically active
compounds
activity against
active pyrrolopyridazine
alkyl
Prior art date
Application number
NO20016099A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016099D0 (no
Inventor
Masahiko Hagihara
Nobuhiko Shibakawa
Keiji Matsunobu
Hiroshi Fujiwara
Keiichi Ito
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries filed Critical Ube Industries
Publication of NO20016099D0 publication Critical patent/NO20016099D0/no
Publication of NO20016099L publication Critical patent/NO20016099L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20016099A 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser NO20016099L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16767999 1999-06-15
PCT/JP2000/003895 WO2000077003A1 (fr) 1999-06-15 2000-06-15 Composes de pyrrolopyridazine optiquement actifs

Publications (2)

Publication Number Publication Date
NO20016099D0 NO20016099D0 (no) 2001-12-14
NO20016099L true NO20016099L (no) 2002-02-07

Family

ID=15854223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016099A NO20016099L (no) 1999-06-15 2001-12-14 Optisk aktive pyrrolopyridazinforbindelser

Country Status (25)

Country Link
US (1) US6670360B2 (fr)
EP (1) EP1186607B1 (fr)
KR (1) KR100583663B1 (fr)
CN (1) CN1170829C (fr)
AT (1) ATE240957T1 (fr)
AU (1) AU757611B2 (fr)
BR (1) BR0011666A (fr)
CA (1) CA2375848A1 (fr)
CZ (1) CZ290935B6 (fr)
DE (1) DE60002860T2 (fr)
DK (1) DK1186607T3 (fr)
ES (1) ES2198319T3 (fr)
HK (1) HK1044341B (fr)
HU (1) HUP0201434A3 (fr)
IL (2) IL147088A0 (fr)
MX (1) MXPA01013011A (fr)
NO (1) NO20016099L (fr)
NZ (1) NZ516194A (fr)
PL (1) PL356479A1 (fr)
PT (1) PT1186607E (fr)
RU (1) RU2222541C2 (fr)
TR (1) TR200103685T2 (fr)
TW (1) TWI287014B (fr)
WO (1) WO2000077003A1 (fr)
ZA (1) ZA200110279B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058901A1 (fr) * 2000-02-10 2001-08-16 Sankyo Company, Limited Compose de pyrrolopyridazine
AU2003266622A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for inhibiting increase in blood gastrin concentration
AU2003266621A1 (en) * 2002-09-25 2004-04-19 Sankyo Company, Limited Medicinal composition for treatment for or prevention of visceral pain
EP1682133A1 (fr) 2003-11-03 2006-07-26 AstraZeneca AB Derives d'imidazo 1,2-a pydirine pour le traitement du reflux gastro-oesophagien sans douleur
KR100958828B1 (ko) 2004-09-03 2010-05-24 주식회사유한양행 피롤로[3,2-ｂ]피리딘 유도체 및 그의 제조방법
CN101003537A (zh) * 2006-01-17 2007-07-25 上海恒瑞医药有限公司 吡咯并哒嗪类衍生物及其制备方法和用途
EP2452680B1 (fr) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Antagoniste de la pompe à acide destiné au traitement de maladies associées à un transit gastro-intestinal anormal
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017164A1 (fr) 1990-04-27 1991-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelles pyridazines
AU8712191A (en) 1990-10-15 1992-05-20 Byk Gulden Lomberg Chemische Fabrik Gmbh New diazines
US5534515A (en) 1991-10-25 1996-07-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrrolopyridazines having gastrointestinal protective effects
ES2185693T3 (es) * 1994-01-19 2003-05-01 Sankyo Co Derivado de pirrolopiridacina.

Also Published As

Publication number Publication date
IL147088A (en) 2006-12-31
ES2198319T3 (es) 2004-02-01
DK1186607T3 (da) 2003-09-01
NO20016099D0 (no) 2001-12-14
MXPA01013011A (es) 2002-11-07
CA2375848A1 (fr) 2000-12-21
KR20020022703A (ko) 2002-03-27
AU5426900A (en) 2001-01-02
NZ516194A (en) 2003-03-28
HUP0201434A2 (en) 2002-08-28
US6670360B2 (en) 2003-12-30
HUP0201434A3 (en) 2003-09-29
KR100583663B1 (ko) 2006-05-26
IL147088A0 (en) 2002-08-14
DE60002860D1 (de) 2003-06-26
EP1186607A4 (fr) 2002-07-03
BR0011666A (pt) 2002-03-19
CN1170829C (zh) 2004-10-13
DE60002860T2 (de) 2004-05-06
ATE240957T1 (de) 2003-06-15
US20020156079A1 (en) 2002-10-24
CZ290935B6 (cs) 2002-11-13
TR200103685T2 (tr) 2002-05-21
HK1044341A1 (en) 2002-10-18
AU757611B2 (en) 2003-02-27
RU2222541C2 (ru) 2004-01-27
EP1186607A1 (fr) 2002-03-13
PL356479A1 (en) 2004-06-28
PT1186607E (pt) 2003-08-29
ZA200110279B (en) 2003-05-28
CZ20014505A3 (cs) 2002-05-15
WO2000077003A1 (fr) 2000-12-21
EP1186607B1 (fr) 2003-05-21
TWI287014B (en) 2007-09-21
HK1044341B (en) 2003-10-03
CN1370172A (zh) 2002-09-18

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
CA2338311A1 (fr) Promedicaments du pyridyle methyle sulfinyle benzimidazoles
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
DE60115465D1 (de) Immunoregulierende verbindungen, deren derivate und ihre verwendung
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
ATE327225T1 (de) Neue verwendung von benzothiazolderivaten
NO20014925L (no) Farmasöytiske forbindelser
WO2002008219A3 (fr) Nouvelles 2-adamantylethylamines et leur utilisation dans le traitement d'etats generalement associes a des anomalies de la transmission glutamatergique
ATE188702T1 (de) Thienodiazepinverbindungen und ihre verwendung
NO20016099L (no) Optisk aktive pyrrolopyridazinforbindelser
WO2003007954A3 (fr) Sulfonyl aryl hydroxamates et leur utilisation comme inhibiteurs des metalloproteases matricielles
HUP0201284A2 (hu) Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
DK0585722T3 (da) Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation
HUP0201282A2 (hu) Hatóanyagként kinazolindionszármazék kimázinhibitort tartalmazó gyógyászati készítmények dermatitisz megelőzésére és kezelésére
NO972731L (no) Thiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel
MXPA04000485A (es) Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa.
NO20013601L (no) Nye morfolinobenzamidsalter
EP1428825A4 (fr) Derives de benzimidazole
NZ329716A (en) Sulfonamide substituted derivatives and medicaments thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application